Editas Medicine Inc buy Slaandjivaa
Start price
22.01.18
/
50%
€30.80
Target price
23.07.18
€34.28
Performance (%)
6.15%
End price
23.07.18
€32.70
Summary
This prediction ended on 23.07.18 with a price of €32.70. With a performance of 6.15%, the BUY prediction by Slaandjivaa for Editas Medicine Inc closed with a slight gain. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Editas Medicine Inc | -19.580% | -19.580% | 36.864% | -74.157% |
| iShares Core DAX® | -2,20 % | 0,67 % | 0,55 % | 51,11 % |
| iShares Nasdaq 100 | -2,63 % | 2,99 % | 34,11 % | 91,99 % |
| iShares Nikkei 225® | -2,02 % | 3,14 % | 53,42 % | 65,85 % |
| iShares S&P 500 | -1,67 % | 2,40 % | 23,22 % | 66,64 % |
Comments by Slaandjivaa for this prediction
In the thread Editas Medicine Inc diskutieren
Edit besser als Crispr?
(Laufzeit überschritten)